STEK · Stemtech Corp

Substantial doubt about the company's ability to continue as a going concern.

“The Company has experienced recurring net losses and negative cash flows from operations since inception and has an accumulated deficit of approximately $36.3 million and a working capital deficiency of approximately $10.5 million at June 30, 2026. The Company has funded its activities to date almost exclusively from debt and equity financing. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”